Nutrition Business Journal

Pharmanex Pursues Balanced Portfolio of Scientific Research

Q&A with Carsten Smidt, VP of Global R&D for Pharmanex

NBJ: How do you decide which scientific studies Pharmanex should pursue and at what level?

CS: All of our R&D projects have a priority score according to a set of criteria that affect the success or failure of new product candidates. The higher the score, the more resources are available, and this also decides the number and type of studies we perform on any given project.

NBJ: How much science does Pharmanex undertake each year?


All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.